NCI Selects ATCC to Distribute Cutting-edge Cancer Models to Support the Human Cancer Models Initiative

10:23 EDT 19 Oct 2016 | PR Newswire

MANASSAS, Va., Oct. 19, 2016 /PRNewswire-USNewswire/ -- The National Cancer Institute (NCI) awarded ATCC, a global leader in biological materials management and standards, a contract to distribute a new generation of cancer models under the Human Cancer Models Initiative (HCMI).

Launched in July 2016, the HCMI is an international collaboration between The National Cancer Institute (NCI), Cancer Research UK, the Wellcome Trust Sanger Institute, and the foundation Hubrecht Organoid Technology, to develop approximately 1,000 cancer cell models that better represent the hallmarks and diversity of human cancer. This initiative leverages prior NCI-funded research to establish protocols for developing these next-generation cancer models.

Under the contract, ATCC will develop the infrastructure to support the intake, authentication, production, quality control, marketing, and distribution of an initial subset of the cancer models, paving the way for the larger collection.

The new models will be generated using tumor tissue from patients with a variety of cancer types, including rare and pediatric cancers, and will include a complete genetic analysis and anonymized clinical information about the patients and their tumors, including their response to treatment.

"ATCC has been supporting cancer research for more than 50 years," said Dr. Mindy Goldsborough, ATCC Chief Science and Technology Officer. "We are honored to support The National Cancer Institute with this important initiative. These new models could transform how we study cancer, including how the disease progresses and develops drug resistance, and help guide the development of new cancer therapies for the millions living with and affected by cancer worldwide."

About ATCCATCC is a leader in biological materials management supporting the scientific community and government with research and development, products, and services in support of global health issues. With a history of innovation spanning 90 years, ATCC offers the world's largest and most diverse collection of human and animal cell lines, microorganisms, biological products, and standards. ATCC is a non-profit organization with headquarters in Manassas, Va. For more information about ATCC, visit us at

Logo -

To view the original version on PR Newswire, visit:

SOURCE American Type Culture Collection


More From BioPortfolio on "NCI Selects ATCC to Distribute Cutting-edge Cancer Models to Support the Human Cancer Models Initiative"

Quick Search

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...